Feasibility of Conducting Autism Biomarker Research in the Clinical Setting

Journal of Developmental and Behavioral Pediatrics

Volumn 38, Issue 7, 2017, Pages 483-492

  Sices, Laura ^a,b   Pawlowski, Katherine ^c   Farfel, Laura ^a,c,d   Phillips, Deirdre ^d   Howe, Yamini ^d,e   Cochran, David M ^f,g   Choueiri, Roula ^f,g   Forbes, Peter W ^c   Brewster, Stephanie J ^c   Frazier, Jean A ^f,g   Neumeyer, Ann ^d,e   Bridgemohan, Carolyn ^c,d  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UMASS MEMORIAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

ASD; autism; autism spectrum disorder; biomarkers; clinical research; feasibility of research; research participation

Indexed keywords

BIOLOGICAL MARKER;

AMBULATORY CARE; AUTISM; CHILD; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AUTISM SPECTRUM DISORDER; BIOMARKERS; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; OFFICE VISITS; OUTPATIENT CLINICS, HOSPITAL;

EID: 85025152263     PISSN: 0196206X     EISSN: 15367312     Source Type: Journal    
DOI: 10.1097/DBP.0000000000000470     Document Type: Article

References (28)

1. Blum NJ, Feldman HM, Barbaresi WJ, et al. Research priorities for developmental-behavioral pediatrics: A DBPNet consensus study. J Dev Behav Pediatr. 2012;33:509-516.
2. Insel TR. The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am J Psychiatry. 2014;171:395-397.
3. Interagency Autism Coordinating Committee (IACC). IACC Strategic Plan for Autism Spectrum Disorder (ASD) Research-2013 Update. April 2014. Retrieved from the U. S. Department of Health and Human Services Interagency Autism Coordinating Committee website: http://iacc. hhs. gov/strategic-plan/2013/index. shtml. plan/2013/index. shtml.
4. National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington, DC: The National Academies Press; 2011.
5. George S, Duran N, Norris K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am J Public Health. 2014;104:e16-e31.
6. Hilton CL, Fitzgerald RT, Jackson KM, et al. Brief report: underrepresentation of African Americans in autism genetic research: A rationale for inclusion of subjects representing diverse family structures. J Autism Dev Disord. 2010;40:633-639.
7. Tanner A, Kim SH, Friedman DB, et al. Barriers to medical research participation as perceived by clinical trial investigators: communicating with rural and African American communities. J Health Commun. 2015;20:88-96.
8. Gabriele S, Sacco R, Persico AM. Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2014;24:919-929.
9. Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci. 2013;14:20508-20542.
10. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: Age-specific changes in anatomical pathology. Brain Res. 2011;1380:138-145.
11. Honekopp J. Digit ratio 2D:4D in relation to autism spectrum disorders, empathizing, and systemizing: A quantitative review. Autism Res. 2012;5:221-230.
12. Miles JH, Takahashi TN, Bagby S, et al. Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A. 2005;135:171-180.
13. Schaefer GB, Mendelsohn NJ. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med. 2008;10:301-305.
14. Lai B, Milano M, Roberts MW, et al. Unmet dental needs and barriers to dental care among children with autism spectrum disorders. J Autism Dev Disord. 2012;42:1294-1303.
15. Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007;120:1162-1182.
16. Davit CJ, Hundley RJ, Bacic JD, et al. A pilot study to improve venipuncture compliance in children and adolescents with autism spectrum disorders. J Dev Behav Pediatr. 2011;32:521-525.
17. American Psychiatric Association Task Force on DSM-IV and American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
18. American Psychiatric Association and American Psychiatric Association DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.
19. Miles JH, Takahashi TN, Hong J, et al. Development and validation of a measure of dysmorphology: useful for autism subgroup classification. Am J Med Genet A. 2008;146A:1101-1116.
20. Manning JT, Scutt D, Wilson J, et al. The ratio of 2nd to 4th digit length: A predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Hum Reprod. 1998;13:3000-3004.
21. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
22. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148:475-486.
23. Aman MG, Singh NN, Stewart AW, et al. The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485-491.
24. Kaat AJ, Lecavalier L, Aman MG. Validity of the aberrant behavior checklist in children with autism spectrum disorder. J Autism Dev Disord. 2014;44:1103-1116.
25. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
26. Christensen DL, Baio J, Van Naarden Braun K, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years-Autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016;65:1-23.
27. McPartland JC, Reichow B, Volkmar FR. Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012;51:368-383.
28. Maenner MJ, Rice CE, Arneson CL, et al. Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. JAMA Psychiatry. 2014;71:292-300.